Tracking markers for neurodegenerative diseases
Part of Brain & nervous system, Eyes & vision, Genetic & congenital, Hormones & metabolism, Mental health clinical trials.
This study tracks changes in people with Parkinson's disease, other movement disorders, or cognitive decline to find better ways to measure disease progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Parkinson's disease, another movement disorder (like multiple system atrophy, progressive supranuclear palsy, or essential tremor), or a cognitive issue (like dementia or memory problems).
- You are willing to participate and understand the study procedures.
- You can complete the research assessments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for proteins in blood and other body fluids that could help detect brain diseases like Parkinson's, Alzheimer's, and ALS early. It aims to improve diagnosis and future treatments.
This study is looking for people with neurodegenerative diseases (like Alzheimer's, Parkinson's, ALS) to help researchers find new markers in the body that could help understand these conditions better and possibly lead to better treatments.
This study looks for “biomarkers” (measurable signs in blood or other samples) in people with motor neuron disease and frontotemporal dementia spectrum conditions. It also compares those findings with matched caregivers, to understand what might be happening in these diseases.
This study looks at how your symptoms, brain imaging (MRI), and genetic factors relate to neurodegenerative conditions. It may help researchers better understand what causes these illnesses and how to classify them.
This trial studies a new imaging agent that helps doctors see brain changes related to Alzheimer's, Parkinson's, and similar conditions. The goal is to improve diagnosis and monitoring of these diseases.
This study looks at early signs of brain diseases like Alzheimer's or Parkinson's before symptoms appear. It uses brain scans and blood tests to find markers that might help predict who will develop these conditions.
Hear when a new Neurodegenerative Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.